The Fullbrook Center Kerrville

The Fullbrook Center Kerrville is an addiction-treatment facility located in Kerrville, TX. The specific care levels offered by The Fullbrook Center Kerrville should be confirmed directly with the admissions team. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at The Fullbrook Center Kerrville

Care-level specifics for The Fullbrook Center Kerrville are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. The useful move is to have an ASAM-aligned assessment done before admission — ideally by someone outside the facility's admissions team — to confirm that the level of care offered here is what the clinical picture calls for.

Insurance and payment

Payment and insurance specifics for The Fullbrook Center Kerrville are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. What tends to produce post-admission financial surprise is not the facility being out of network — it is the verbal assurance that did not make it into writing. Ask for the written VOB before admission, save the email, and the rest of the financial conversation becomes a lot simpler.

Before you call

Three questions to put to The Fullbrook Center Kerrville before admission: the specific ASAM level the facility is billing; the written Verification of Benefits for your specific plan product; the MAT policy (continuation of buprenorphine or methadone during residential, specifically). If the clinical situation involves opioid use disorder, confirm explicitly whether The Fullbrook Center Kerrville offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. Getting answers in writing protects against the downstream surprises.